Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about CYBN

Recent news which mentions CYBN

< Previous 1 2 3 4 5 6 7 8 9

...

Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More

January 12, 2024

30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond

January 10, 2024

Cybin Inc's Two Deuterated Psychedelic Molecules Achieve Positive Topline Clinical Results

January 09, 2024

Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD

January 06, 2024

Psychedelic Stock Gainers And Losers From January 1, 2024

January 01, 2024

Mind-Bending Growth: 3 Psychedelic Stocks With Trippy Potential

December 14, 2023

Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More

December 05, 2023

Cybin's Novel Psilocybin Topline Data: 79% Remission In Major Depression Symptoms, What's Next?

December 03, 2023

Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More

November 24, 2023

GH Research, Compass Pathways Among Top Psychedelic Movers Of Today

November 23, 2023

Analyst Expectations for Cybin's Future

November 17, 2023

Expedia To Rally Around 54%? Here Are 10 Top Analyst Forecasts For Friday

November 17, 2023

Cybin Reports Access To $101M To Sustain Deuterated Psychedelics Programs, Q2 Numbers & 2024 Goals

November 15, 2023

Psyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & More

November 12, 2023

Cybin Launches Five-Day Units Offering For Up To $64M, Suspends Prior LPC Funding Deal

November 10, 2023

Psyched: DEA's Denial Overruled, Fed Psychedelics Change, Psilocybin For Depression, States Reform & More

November 06, 2023

Single Dose Of Cybin's Psilocybin Shows Compelling Patient Outcomes, Phase 2 Results Find

November 01, 2023

Psyched: Cybin's Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney's Memoirs And More

October 29, 2023

Cybin's Deuterated Psychedelics Programs Protected By Three New International Patents

October 26, 2023

Cybin Officially Owns Small Pharma: Plans For New 'International Leader' In Psychedelic Therapeutics

October 23, 2023

Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted

October 22, 2023

Small Pharma's Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT Business

October 20, 2023

Moving Closer To Cybin Acquisition, Small Pharma Obtains Final Order Approving Arrangement

October 18, 2023

Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More

October 16, 2023

Cybin And Small Pharma Shareholders Green Light Acquisition Resolution: Results & Expected Dates

October 13, 2023

Psyched: Steve Cohen's New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More

October 06, 2023

Cybin Completes Dosing In Phase 2 Study Of CYB003 For Major Depressive Disorder Treatment

October 03, 2023

Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares

October 03, 2023

Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More

October 02, 2023

Cybin And Fluence Partner To Support EMBARK Training For Phase 3 CYB003 Trial For Depression

September 26, 2023

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.